11
May

08:00 AM PDT

Clinical Operations

Strategy Meeting West Coast USA 2022

The premier meeting for all West Coast USA Clinical Operations professionals

The Westin St. Francis San Francisco on Union Square

A MEETING EXPERIENCE UNLIKE ANY OTHER

Fresh Clinical Operations Insights

Tired of the same conference experience? Real discussions and genuine networking are often promised, but not always delivered.

Proventa International’s Clinical Strategy Meetings are designed to avoid the pitfalls of a typical conference, by providing the right environment to make those important connections through interactive roundtable discussions, exclusive networking and keynote panel debates. Join Clinical Operations professionals from across the West Coast in San Francisco, to discover new insights and take your company’s mission to the next level.

What makes our strategy meetings unique?

Roundtable Discussions

Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.

Unrivalled Networking

With senior delegation from big pharma and innovative biotech from across the West Coast, you can network with peers from different locations, all in one place.

Personalised Agenda

Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.

Solutions to your Problems

We’ve partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.

Industry Researched Topics

We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.

Senior Decision Makers

The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.

Become an official strategy meeting partner

Whatever your business needs, we can help. Get in touch for partnering opportunities

I’D LIKE TO PARTNER

Press play to hear what your colleagues had to say…

See the agenda and facilitator line-up

Download the strategy meeting brochure for full details

DOWNLOAD THE BROCHURE

Meet the 2022 Facilitators

Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at our upcoming strategy meeting:

Krista Bradley, MBA, RN

VP & General Manager – Research Nursing & Phlebotomy Solutions – Decentralized Trials IQVIA

Melissa Easy

Vice President, Clinical Technology Offerings IQVIA Technologies

Katy Preciado

Decentralized Clinical Trial Solutions Director IQVIA R&D Solutions

Eli Damron-Rodriguez

Associate Director, RBQM IQVIA Technologies

Gayle Hamilton

Director, RBQM, Digital Trial Management Suite IQVIA Technologies

Sarrah Val

MPH Vice President of Global Sales MD GROUP

Claudia Hesselmann, PhD

Co-founder & CEO ARENSIA

Tatiana Eidus

Director Corporate Development North America, USA Arensia

Matthew Gordon

VP, Real-World Evidence Strategy Parexel Biotech

Roman Hrynchuk

Chief Operating Officer Sanaclis

Dario Lirio

Senior Director, Product Management Clinical ArisGlobal

Anita Modi

VP, Business Transformation Science 37

Scott Chetham

Co-Founder, CEO Faro Health

Dr. Udayasankar Arulmani

Vice President, Global Clinical Development and Operations Santen Pharmaceuticals

Dr. Uday Arulmani is currently employed in Santen as VP Global Clinical Development and Operations (GCDO). Dr. Uday Arulmani is the clinical trial officer for Santen Pharmaceuticals which is a renowned company specializing in ophthalmic drugs worldwide.
Dr. Uday Arulmani received his medical degree from Madras Medical College, Madras, India. Following his medical degree, he completed his senior residency in Rheumatology and Immunology in Government General Hospital in Madras, India.
In 2000, Dr. Arulmani was awarded a Dutch fellowship to pursue his Master’s in Clinical Epidemiology at the Erasmus Medical Center, Rotterdam, The Netherlands. Following his successful completion of Master’s degree, he continued his PhD in clinical pharmacology.  In addition, Dr. Arulmani received his MBA education from Heriott Watt University, Edinburgh.
Dr. Uday Arulmani has 15 years of pharmaceutical industry experience at major pharmaceutical
companies. He has been serving most recently as a Senior Director, Clinical research in Gilead sciences where he has led the inflammatory bowel disease programs. Previously, he served in different leadership positions at Genentech, Abbvie/Abbott and Novartis Pharma AG (Basel, Switzerland).  Dr. Uday Arulmani has published several peer reviewed articles in international journals and abstracts in major international conferences.  
Dr. Arulmani is passionate in decentralized clinical trials, digital technology and artificial intelligence in clinical development.

Jason Carlton

Vice President, Clinical Operations Jasper Therapeutics

Mr. Carlton joined Jasper Therapeutics in January 2022 as Vice President, Clinical Operations. He has nearly 25 years of industry experience in clinical operations in all phases of clinical development. Before joining Jasper, he was at Genentech where he worked for 3 years as the Therapeutic Area Head, Global Clinical Operations serving the operations teams responsible for all the early development programs within Ophthalmology, CNS, Infectious Disease and Metabolism portfolios. Before that, he was Executive Director, Clinical Operations at Ultragenyx, serving the clinical operations group that successfully led to the company’s first approved therapies for rare and ultra-rare diseases. Before joining Ultragenyx he was an Operations Program Director within Genentech’s late-stage clinical development group for 4 years helping build an ophthalmology franchise that included their first large global phase III registrational program. Prior to joining Genentech, he was a Global Operations Program Leader at Biogen for 4 years leading the TYSABRI clinical operations team and was the global development team lead for the program. He started his career at Merck and led several clinical programs in various therapeutic areas including vaccines, infectious diseases and obesity. Mr. Carlton holds a B.A. in Biology from La Salle University.

Richard Murg

Global Vice President, Business Development Clario

Richard Murg is the Global Vice President of Business Development for the eClinical Solutions Division of Clario. He is responsible for Sales and Marketing and also partners with internal teams to assist in improving products, services and processes that better align with customers’ needs and the long-term growth of Clario eClinical. Richard came to Bioclinica in 2006 as the second salesperson, responsible for the Western United States.  In 2016, became the Vice President of Sales Mid-Markets. During his tenure he was individually responsible for more than $150M in sales and growing annual software sales to greater than $50M.  Due to this success, Richard was engaged by MedNet Solutions to become their Chief Revenue Officer in 2017. There, he increased sales 25% and led them to record bookings in 2018. In 2019, he was recruited back to Bioclinica to recreate his past successes through growing and mentoring the sales team, reposition/expanding the sales tools (marketing) and products to make a significant impact.  Richard is a West Point graduate, has earned an MBA and is a war veteran.

Farah Anwar

Vice President Head of Development Operations Sana Biotechnology

Jenny Chaplin

Vice President, Strategic Operations Bellicum Pharmaceuticals

Ly Kawaguchi

Executive Director, Head of Clinical Outsource and Vendor Governance Curis

Ana Krtolica

Senior Vice President, Preclinical Development Oryn Therapeutics

Suresh Dheerendra

Vice President of Clinical Operations Neuron23 Inc.

Amir Lahav

Digital Healthcare Innovation, Head of Strategic R&D Mitsubishi Tanabe Pharma

Bio: Dr. Amir Lahav is a leading innovator, brain scientist, and an internationally acclaimed advisor in digital health innovation. He has 20 years of experience in the healthcare industry, academic research, clinical trial innovation, and AI-driven technology. Amir’s visionary leadership and changemaker mentality help mobilize the adoption of digital transformation and virtual health. In addition to holding Advisory Board roles at multiple Medtech companies, Amir is also a distinguished consultant to technology startups, pharmaceutical companies, and healthcare organizations including Mitsubishi Tanabe Pharma, Global Alzheimer’s Platform Foundation, Redenlab, and SoloAI to name a few. Formerly, Amir was the Head of Digital Innovation at Pfizer focusing primarily on rare neuromuscular diseases. Prior to pharma, Amir was a professor of pediatrics and neurology faculty at Harvard Medical School where he served as a PI on multiple technology-driven clinical trials.

Prasun Mishra

CEO, Founder / CEO, Founding President r, Agility Pharmaceuticals / American Association for Precision Medicine (AAPM)

Quick Links

Want to find out more?

Find out more details about our Strategy Meetings and other news and events.

Here To Help

Want to know more? Interested in sponsoring the event? Need help registering your team? Just get in touch and a member of the team will be happy to help.

14 May 2024

Drug Discovery Biology & Bioinformatics Strategy Meeting East Coast USA 2024

21 May 2024

Drug Discovery Biology & Bioinformatics Strategy Meeting West Coast USA 2024

22 Oct 2024

Drug Discovery Biology & Bioinformatics Strategy Meeting Europe 2024

11 Nov 2024

Bioinformatics and IT Strategy Meeting East Coast USA 2024

16 May 2024

Clinical Operations and Clinical Trial Supply Chain Strategy Meeting East Coast USA 2024

23 May 2024

Clinical Operations and Clinical Trial Supply Chain Strategy Meeting West Coast USA 2024

14 Nov 2024

Clinical Operations & Clinical Trial Supply Chain Strategy Meeting East Coast USA 2024

12 Nov 2024

Drug Discovery Biology Strategy Meeting East Coast USA 2024

15 May 2024

Medicinal Chemistry Strategy Meeting East Coast USA 2024

22 May 2024

Medicinal Chemistry Strategy Meeting West Coast USA 2024

23 Oct 2024

Medicinal Chemistry Strategy Meeting Europe 2024

13 Nov 2024

Medicinal Chemistry Strategy Meeting East Coast USA 2024

Europe

USA East

USA West

Webinars

Dinners & Spotlights

R&D

Clinical Trials San Francisco

Clinical Operations

Strategy Meeting West Coast USA 2022

<img class="lazy" decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://proventainternational.com/wp-content/uploads/2020/12/location.png" >The Westin St. Francis San Francisco on Union Square

Fresh Clinical Operations Insights

What makes our strategy meetings unique?

Roundtable Discussions

Unrivalled Networking

Personalised Agenda

Solutions to your Problems

Industry Researched Topics

Senior Decision Makers

Become an official strategy meeting partner

Press play to hear what your colleagues had to say…

See the agenda and facilitator line-up

Meet the 2022 Facilitators

Krista Bradley, MBA, RN

Melissa Easy

Katy Preciado

Eli Damron-Rodriguez

Gayle Hamilton

Sarrah Val

Claudia Hesselmann, PhD

Tatiana Eidus

Matthew Gordon

Roman Hrynchuk

Dario Lirio

Anita Modi

Scott Chetham

Dr. Udayasankar Arulmani

Jason Carlton

Richard Murg

Farah Anwar

Jenny Chaplin

Ly Kawaguchi

Ana Krtolica

Suresh Dheerendra

Amir Lahav

Prasun Mishra

Lead Sponsor

Our 2022 Thought Leader

Our 2022 Co-hosts Sponsors

Want to find out more?

Here To Help

Select days you wish to attend You can add multiple days

Daily Delegate Rate includes:

VAT Excluded

Select days you wish to attend You can add multiple days

Pass includes:

VAT Excluded

14
May
2024

21
May
2024

22
Oct
2024

11
Nov
2024

16
May
2024

23
May
2024

14
Nov
2024

12
Nov
2024

15
May
2024

22
May
2024

23
Oct
2024

13
Nov
2024

The Westin St. Francis San Francisco on Union Square